Table 2.

Effect of IUD use on PID within 3-months of enrollment, survey data (N=272)

	Same-day IUD % (n) [95% CI] n=28	Delayed IUD placement % (n) [95% CI] n=17	No IUD within 3 months % (n) [95% CI] n=227	P value (Same-day vs. Delayed IUD)	P value (Same-Day IUD vs. No IUD)
PID diagnosis in past 3 months (n=270)	3.6 % (1) [0.0–10.4%]	11.8% (2) [0.0–27.1%]	4.9% (11) [2.7–8.6%]	0.54*	1.00*
Pelvic pain in past 3 months (n=270)	50.0%(14) [31.5–68.5%]	43.8%(7) [19.4–68.1%]	26.6% (60) [21.2–32.7%]	0.69	0.02
Tested for an STI in past 3 months for any reason (n=269)	35.7% (10) [18.0–53.5%]	35.3% (6) [12.6–58.0%]	43.3% (97) [37.0–49.9%]	0.98	0.44
Tested for an STI if reported pelvic pain (n=81)	42.9% (6) [16.9–68.8%]	28.6% (2) [0–62.0%]	65.0% (39) [52.3–75.9%]	0.53	0.13
Treated for an STI in the past 3 months whether or not tested (n=269)	14.3% (4) [1.3–27.2%]	5.9% (1) [0–17.1%]	17.0% (38) [12.6–22.5%]	0.64*	1.00*
Treated for STI if tested for STI (n=110)	40.0% (4) [9.6–70.4%]	16.7% (1) [0–46.5%]	36.2% (34) [27.2–46.3%]	0.59*	1.00*
Condoms in 3 months following enrollment (n=272)	57.1% (16) [38.8–75.5%]	52.9% (9) [29.2–76.7%]	59.9% (136) [53.4–66.1%]	1.00*	0.78
Most effective contraceptive since enrollment
IUD	100% (28)	100% (17)	-
Hormonal	-	-	56.4% (128)
Condoms	-	-	30.0% (68)
None	-	-	13.7% (31)

^*Fisher’s exact p-value reported when cell values <5, in all other cases chi-square tests were used.